Display options
Share it on

Parkinsons Dis. 2017;2017:7380102. doi: 10.1155/2017/7380102. Epub 2017 Mar 19.

Correlation of MRI Visual Scales with Neuropsychological Profile in Mild Cognitive Impairment of Parkinson's Disease.

Parkinson's disease

Luiz Felipe Vasconcellos, João Santos Pereira, Marcelo Adachi, Denise Greca, Manuela Cruz, Ana Lara Malak, Helenice Charchat-Fichman, Mariana Spitz

Affiliations

  1. Movement Disorders Unit, Neurology Service, Pedro Ernesto University Hospital, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  2. Radiology Department, Hospital Central da Polícia Militar, Rio de Janeiro, RJ, Brazil.
  3. Psychology Department, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, RJ, Brazil.

PMID: 28409050 PMCID: PMC5376452 DOI: 10.1155/2017/7380102

Abstract

Few studies have evaluated magnetic resonance imaging (MRI) visual scales in Parkinson's disease-Mild Cognitive Impairment (PD-MCI). We selected 79 PD patients and 92 controls (CO) to perform neurologic and neuropsychological evaluation. Brain MRI was performed to evaluate the following scales: Global Cortical Atrophy (GCA), Fazekas, and medial temporal atrophy (MTA). The analysis revealed that both PD groups (amnestic and nonamnestic) showed worse performance on several tests when compared to CO. Memory, executive function, and attention impairment were more severe in amnestic PD-MCI group. Overall analysis of frequency of MRI visual scales by MCI subtype did not reveal any statistically significant result. Statistically significant inverse correlation was observed between GCA scale and Mini-Mental Status Examination (MMSE), Montreal Cognitive Assessment (MoCA), semantic verbal fluency, Stroop test, figure memory test, trail making test (TMT) B, and Rey Auditory Verbal Learning Test (RAVLT). The MTA scale correlated with Stroop test and Fazekas scale with figure memory test, digit span, and Stroop test according to the subgroup evaluated. Visual scales by MRI in MCI should be evaluated by cognitive domain and might be more useful in more severely impaired MCI or dementia patients.

References

  1. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4 - PubMed
  2. Lancet Neurol. 2012 Aug;11(8):697-707 - PubMed
  3. AJR Am J Roentgenol. 1987 Aug;149(2):351-6 - PubMed
  4. Eur Neurol. 1996;36(5):268-72 - PubMed
  5. Brain. 2007 Jul;130(Pt 7):1787-98 - PubMed
  6. Mov Disord. 2007 Dec;22(16):2314-24 - PubMed
  7. Neurology. 2005 Mar 8;64(5):861-5 - PubMed
  8. J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1225-33 - PubMed
  9. Brain. 2008 May;131(Pt 5):1294-302 - PubMed
  10. Rev Bras Psiquiatr. 2013 Apr-Jun;35(2):178-85 - PubMed
  11. J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):967-72 - PubMed
  12. J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):315-21 - PubMed
  13. Mov Disord. 2012 Mar;27(3):349-56 - PubMed
  14. J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):7-16 - PubMed
  15. J Neurol Sci. 2011 Nov 15;310(1-2):70-4 - PubMed
  16. Parkinsonism Relat Disord. 2013 Jul;19(7):680-3 - PubMed

Publication Types